CLINICAL TRIALS PROFILE FOR INVANZ
✉ Email this page to a colleague
All Clinical Trials for INVANZ
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00379951 ↗ | A Study to Assess the Safety, Tolerability and Efficacy of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-048) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2005-06-01 | The purpose of this study is to evaluate the safety, tolerability and efficacy of ertapenem sodium as initial therapy for the treatment of complicated urinary tract infections, including pyelonephritis in indian adults. |
NCT00397956 ↗ | To Evaluate the Treatment Effect of an Anti-Infective Agent for Complicated Infections (0826-053) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2004-09-01 | To collect clinical response data with the use of ertapenem in community acquired sepsis. |
NCT00398099 ↗ | To Evaluate the Treatment Effect of an Anti-Infective Agent for Different Kinds of Infections (0826-052) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2005-07-01 | To collect clinical response data with the use of ertapenem in approved indications. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for INVANZ
Condition Name
Clinical Trial Locations for INVANZ
Trials by Country
Clinical Trial Progress for INVANZ
Clinical Trial Phase
Clinical Trial Sponsors for INVANZ
Sponsor Name